IMOWX
Price
$26.44
Change
+$0.57 (+2.20%)
Updated
Oct 13 closing price
Net Assets
696.46M
PMBCX
Price
$36.08
Change
+$0.39 (+1.09%)
Updated
Oct 13 closing price
Net Assets
32.13B
Interact to see
Advertisement

IMOWX vs PMBCX

Header iconIMOWX vs PMBCX Comparison
Open Charts IMOWX vs PMBCXBanner chart's image
Voya MidCap Opportunities W
Price$26.44
Change+$0.57 (+2.20%)
VolumeN/A
Net Assets696.46M
Principal MidCap C
Price$36.08
Change+$0.39 (+1.09%)
VolumeN/A
Net Assets32.13B
IMOWX vs PMBCX Comparison Chart in %
View a ticker or compare two or three
VS
IMOWX vs. PMBCX commentary
Oct 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMOWX is a Buy and PMBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMBCX has more cash in the bank: 32.1B vs. IMOWX (696M). IMOWX (0.00) and PMBCX (0.00) have matching dividends . IMOWX was incepted earlier than PMBCX: IMOWX (16 years) vs PMBCX (19 years). PMBCX (1.75) is less costly to investors than IMOWX (0.94). IMOWX is a more actively managed with annual turnover of: 87.00 vs. PMBCX (10.50). IMOWX (1000) and PMBCX (1000) have matching initial minimum investment requirements. IMOWX annual gain was more profitable for investors over the last year : 1.21 vs. PMBCX (-3.07). PMBCX return over 5 years is better than : 26.34 vs. IMOWX (-12.04).
IMOWXPMBCXIMOWX / PMBCX
Total Expense Ratio0.941.7554%
Annual Report Gross Expense Ratio0.941.7554%
Fund Existence16 years19 years-
Gain YTD5.8081.681346%
Front LoadN/AN/A-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets696M32.1B2%
Annual Yield % from dividends0.000.00-
Returns for 1 year1.21-3.07-40%
Returns for 3 years46.0849.0894%
Returns for 5 years-12.0426.34-46%
Returns for 10 years4.0674.355%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CADL6.470.28
+4.52%
Candel Therapeutics
CFR125.322.49
+2.03%
Cullen/Frost Bankers
AACBU10.40N/A
N/A
Artius II Acquisition Inc
JANX26.29-0.22
-0.83%
Janux Therapeutics
RECT3.56-0.29
-7.53%
Rectitude Holdings Ltd